Does NIVOLUMAB Cause Intentional product use issue? 3,297 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,297 reports of Intentional product use issue have been filed in association with NIVOLUMAB (OPDIVO). This represents 3.8% of all adverse event reports for NIVOLUMAB.
3,297
Reports of Intentional product use issue with NIVOLUMAB
3.8%
of all NIVOLUMAB reports
1,461
Deaths
827
Hospitalizations
How Dangerous Is Intentional product use issue From NIVOLUMAB?
Of the 3,297 reports, 1,461 (44.3%) resulted in death, 827 (25.1%) required hospitalization, and 143 (4.3%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 3,297 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
Dyspnoea (2,527)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
LEFLUNOMIDE (3,280)
HYDROXYCHLOROQUINE (3,059)
Which NIVOLUMAB Alternatives Have Lower Intentional product use issue Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE